Device Therapy Targeting the Neurohormonal Pathway in Heart Failure Patients Barostim is a novel device therapy that works with guideline-directed medical therapy and targets the... Read More
Barostim Late-Breaking Data from THT 2025: Roundtable Discussion with Dr. Phil Adamson Following THT 2025, Dr. Phil Adamson, Chief Medical Officer of CVRx, led a virtual roundtable discussion with Dr.... Read More
Barostim's Role in Heart Failure Management: Q&A with Dr. Debbie Rinde-Hoffman Debbie A. Rinde-Hoffman, MD, FACC is an Advanced Heart Failure and Transplant Cardiologist and the Vice Chief HVI... Read More
Integrating Barostim into a Comprehensive Heart Failure Program at ISHLT 2024 Did you miss our symposium at ISHLT 2024? Watch the recordings to hear an expert faculty panel featuring Drs.... Read More
Barostim at THT 2024 Attending THT 2024 next week? Join us in Boston to learn about the long-term benefits of Barostim. Read More